No Clear Answers From MS Drug Discontinuation Trial

The first randomized trial to examine if older adults with multiple sclerosis can discontinue disease-modifying therapy after years of being relapse-free failed to deliver a definitive conclusion.
Medscape Medical News

Leave a Reply

Your email address will not be published.